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Abstract
Background: Staphylococcus aureus is a highly adaptable human pathogen and there is a constant search for effective 
antibiotics. Fosfomycin is a potent irreversible inhibitor of MurA, an enolpyruvyl transferase that uses 
phosphoenolpyruvate as substrate. The goal of this study was to identify the pathways and processes primarily 
affected by fosfomycin at the genome-wide transcriptome level to aid development of new drugs.
Results: S. aureus ATCC 29213 cells were treated with sub-MIC concentrations of fosfomycin and harvested at 10, 20 
and 40 minutes after treatment. S. aureus GeneChip statistical data analysis was complemented by gene set 
enrichment analysis. A visualization tool for mapping gene expression data into biological pathways was developed in 
order to identify the metabolic processes affected by fosfomycin. We have shown that the number of significantly 
differentially expressed genes in treated cultures increased with time and with increasing fosfomycin concentration. 
The target pathway - peptidoglycan biosynthesis - was upregulated following fosfomycin treatment. Modulation of 
transport processes, cofactor biosynthesis, energy metabolism and nucleic acid biosynthesis was also observed.
Conclusions: Several pathways and genes downregulated by fosfomycin have been identified, in contrast to 
previously described cell wall active antibiotics, and was explained by starvation response induced by 
phosphoenolpyruvate accumulation. Transcriptomic profiling, in combination with meta-analysis, has been shown to 
be a valuable tool in determining bacterial response to a specific antibiotic.
Background
Staphylococcus aureus is a common human pathogen. It
is known to be highly adaptable, as shown in the rapid
development of resistance to most known antibiotics.
Much research in the last decade has been devoted to dis-
covering new broad-spectrum antibiotic agents. A large
proportion of effective antibiotics act on the cell wall
which has been taken as an adequate target in the devel-
opment of new drugs. Most cell wall active antibiotics in
clinical use, for example β-lactams and glycopeptides, act
by inhibiting late steps of peptidoglycan synthesis on the
outer side of the cell membrane. The enzymes that cata-
lyze the intracellular part of the peptidoglycan synthesis
pathway, muramyl peptide ligases (Mur enzymes), are
also good candidates for antibiotic drug targeting,
because human cells do not synthesize similar enzymes.
Inhibition of these enzymes causes substantial impair-
ment of bacterial cell wall biosynthesis which, at higher
doses of inhibitor, leads to decreased cell growth and to
cell lysis. However , only two antibiotic agents targeting
Mur enzymes are in clinical use, fosfomycin and cycloser-
ine. Fosfomycin is a potent irreversible inhibitor of
MurA, an enolpyruvyl transferase that catalyses the con-
densation of uridine diphosphate-N-acetylglucosamine
with phosphoenolpyruvate (PEP) [1]. This reaction is the
first step in the peptidoglycan biosynthesis pathway.
* Correspondence: marko.petek@nib.si
1 Department of Biotechnology and Systems Biology, National Institute of 
Biology, Večna pot 111, Ljubljana, SI-1000, Slovenia
† Contributed equally
Full list of author information is available at the end of the articlePetek et al. BMC Microbiology 2010, 10:159
http://www.biomedcentral.com/1471-2180/10/159
Page 2 of 12
Genome-scale expression profiling, using microarray
technology, can be used to determine potential drug tar-
gets [2]. The Staphylococcus aureus microarray meta-
database (SAMMD, [3]) contains sets of differentially
expressed genes, identified by published S. aureus expres-
sion profiling experiments. This database simplifies com-
parison of experimental data and provides a quick
overview of published experiments for this bacterium.
Our goal is to develop a platform for transcriptional
profiling of new Mur ligase inhibitors. As a reference, the
transcription profile was determined for the well charac-
terized inhibitor of MurA ligase, fosfomycin. We have
focused on the pathways and processes primarily affected
by fosfomycin. In contrast to other genome-wide profil-
ing studies of pathogen responses to antimicrobial sub-
stances, we have studied the response to low
concentrations of antimicrobial agent early after its addi-
tion. An innovative data analysis approach, comple-
mented by newly devised visualization tools, pathway
analysis and meta-analysis of similar experiments,
enabled us to identify differentially expressed gene
groups and pathways, and to conclude that the response
of the bacterium to fosfomycin is not only time but also
concentration dependent.
Results and discussion
The experiment was designed to enable detection of pri-
mary effects of fosfomycin treatment, as opposed to the
cell death related effects observed after prolonged expo-
sure to high drug concentrations. The longest time of
e x p o s u r e  w a s  c h o s e n  t o  b e  4 0  m i n ,  w h i c h  i s  a p p r o x i -
mately one cell cycle. Two concentrations of fosfomycin
were used, 1 μg/ml and 4 μg/ml, which affected bacterial
growth only slightly (results not shown). The samples
were processed and the data obtained analyzed according
to strict protocol as shown schematically in Figure 1.
Time and concentration dependent effects of fosfomycin
The profile of differentially expressed genes varied sub-
stantially with time following treatment with fosfomycin.
After ten minutes, only a small proportion of genes were
significantly differentially expressed (Figure 2). This first
time point was too short to detect global changes at the
level of gene expression. The reaction to fosfomycin
became more evident after 20 min and 40 min of incuba-
tion. The greatest number of differentially expressed
genes was found at 4 μg/ml fosfomycin concentration,
after 40 min incubation (t40c4) (Figure 2 and Figure 3).
Not surprisingly, at both concentrations, the later time
points were more similar to one another than to the time
point 10 min of incubation in terms of common differen-
tially expressed genes (Figure 2).
The concentration dependence of the transcriptome
response was also observed at the individual gene level.
For example, alanine racemase gene SA1231, some trans-
porter genes (opp2B, SA1183, SA1972, msmX, SA0207,
malF) and amino acid biosynthesis genes dhoM and hisC
were significantly differentially expressed only at higher
concentrations of fosfomycin (see Additional file 1).
Metabolic pathways affected by fosfomycin treatment
Analysis of gene groups and metabolic pathways is suit-
able for biological interpretation of microarray analysis
results, where grouping is essential to retain the overview.
We have chosen TIGRFAM functional classification to
Figure 1 Experimental workflow outlining the microarray data 
analysis procedure.
Figure 2 Venn diagrams of differentially expressed genes in fos-
fomycin treated vs. control S. aureus cultures. Circles show num-
bers of differentially expressed genes (UP- upregulated, DOWN- 
downregulated) 10, 20 and 40 minutes after treatment with 1 μg/ml 
(left) and 4 μg/ml (right) of fosfomycin.Petek et al. BMC Microbiology 2010, 10:159
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group S. aureus genes by the known or predicted bio-
chemical role of the protein they encode. The greatest
proportion of differentially expressed genes belong to the
groups "cell envelope", "transport and binding proteins"
and "energy metabolism", indicating that these were the
processes affected most by fosfomycin (Figure 3). A
global transcriptional response became evident after 20
min of incubation. Interestingly, mainly the same pro-
cesses were affected at both concentrations.
The results of pathway analysis obtained by the differ-
ent approaches - one classifying differentially expressed
genes (Figure 3), the other comparing the whole expres-
sion profiles by gene set enrichment analysis (GSEA)
(Table 1) - were similar, confirming the biological signifi-
cance of the results. Both approaches show that fosfomy-
cin downregulated genes for amino acid biosynthesis,
transport, and energy metabolism, but upregulated those
for protein synthesis and protein fate (protein modifica-
tion, trafficking, repair, and folding). Interestingly, GSEA
shows that for cell envelope genes, purine and pyrimidine
biosynthesis, and for regulatory genes, the switch in tran-
scription regulation, occurred 20 min after treatment.
The upregulation of genes for cell division after 40 min of
treatment (Table 1) is important, since many components
of this process are involved in cell envelope biosynthesis.
To strengthen the reliability of the microarray data,
qPCR analysis was performed for five differentially
expressed genes - two peptidoglycan biosynthesis genes,
murZ and sgtB, autolysin gene atl, cofactor biosynthesis
gene ribB and oligopeptide transporter gene oppB (Figure
4).
Cell envelope synthesis is strongly affected by fosfomycin 
treatment
The GSEA results showed that specific subgroups of
genes in the cell envelope group were regulated differ-
ently (Table 1). Genes involved in murein and peptidogly-
can biosynthesis, including teichoic acid biosynthesis
genes, were upregulated, while surface polysaccharide
metabolism genes were downregulated.
To interpret the changes in gene expression we visual-
ized the data in Pathway Studio software. Since the pepti-
doglycan biosynthesis pathway is not complete in the
existing metabolic network [4], the pathway was comple-
mented with literature data. The .gpc file (Additional file
2) can be used by the scientific comunity to interpret
gene expression data, enabling ready visual comparison
of experimental results from different studies.
F osfomycin caused weak upregulation of several mur
genes (murIDZ, mraY) that encode enzymes involved in
Figure 3 Differentially expressed genes corresponding to TIGRFAM protein superfamilies. The percentage of differentially expressed genes 
(upper panel - upregulated genes, lower panel - downregulated genes) vs. total number of genes in TIGRFAM protein superfamilies (AA_b: Amino 
acid biosynthesis; CF_b: Biosynthesis of cofactors, prosthetic groups, and carriers; C_env: Cell envelope; C_pro: Cellular processes; C_int: Central inter-
mediary metabolism; DNA_m: DNA metabolism; Ene_m: Energy metabolism; Fat_m: Fatty acid and phospholipid metabolism; Mobi: Mobile and ex-
trachromosomal element functions; P_fat: Protein fate; P_syn: Protein synthesis; Pu_py: Purines, pyrimidines, nucleosides, and nucleotides; Reg_f: 
Regulatory functions; Sig_t: Signal transduction; Trans: Transcription; Tr_bi: Transport and binding proteins; Uncl: Unclassified) at 10, 20 and 40 minutes 
after treatment with 1 μg/ml (left) and 4 μg/ml (right) of fosfomycin.Petek et al. BMC Microbiology 2010, 10:159
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Table 1: Enriched gene sets after 10, 20 and 40 minutes of treatment with fosfomycin.
Downregulation Upregulation
Gene set 10 min 20 min 40 min 10 min 20 min 40 min
AMINO ACID BIOSYNTHESIS_ASPARTATE FAMILY 0.000 0.003 0.005
AMINO ACID BIOSYNTHESIS_OTHER 0.171
TRANSPORT AND BINDING PROTEINS_AMINO ACIDS, PEPTIDES AND 
AMINES
0.000 0.010
TRANSPORT AND BINDING PROTEINS_CARBOHYDRATES, ORGANIC 
ALCOHOLS, AND ACIDS
0.090 0.008
TRANSPORT AND BINDING PROTEINS_CATIONS AND IRON 
CARRYING COMPOUNDS
0.078 0.228
TRANSPORT AND BINDING PROTEINS_UNKNOWN SUBSTRATE 0.092 0.022
ENERGY METABOLISM_AMINO ACIDS AND AMINES 0.135 0.008
ENERGY METABOLISM_ATP-PROTON MOTIVE FORCE 
INTERCONVERSION, BIOSYNTHESIS AND DEGRADATION OF 
POLYSACCHARIDES, PYRUVATE DEHYDROGENASE
0.005
ENERGY METABOLISM_GLYCOLYSIS_GLUCONEOGENESIS 0.088 0.238
ENERGY METABOLISM_SUGARS AND TCA CYCLE 0.077 0.089
SIGNAL TRANSDUCTION_PTS 0.033 0.008
CELL ENVELOPE_BIOSYNTHESIS AND DEGRADATION OF MUREIN 
SACCULUS AND PEPTIDOGLYCAN
0.068 0.015
CELL ENVELOPE_BIOSYNTHESIS AND DEGRADATION OF SURFACE 
POLYSACCHARIDES AND LIPOPOLYSACCHARIDES
0.000 0.009 0.228
CELL ENVELOPE_OTHER 0.087
CELLULAR PROCESSES_CELL DIVISION 0.238 0.051
CELLULAR PROCESSES_PATHOGENESIS 0.237
CELLULAR PROCESSES_TOXIN PRODUCTION AND RESISTANCE 0.068
CENTRAL INTERMEDIARY METABOLISM_NITROGEN METABOLISM 
AND AMINO SUGARS
0.046
CENTRAL INTERMEDIARY METABOLISM_OTHER 0.140
PURINES, PYRIMIDINES, NUCLEOSIDES, AND NUCLEOTIDES 0.000 0.036
REGULATORY FUNCTIONS_OTHER 0.169
PROTEIN SYNTHESIS_TRNA AMINOACYLATION 0.083
PROTEIN FATE_DEGRADATION OF PROTEINS, PEPTIDES, AND 
GLYCOPEPTIDES
0.238 0.220
PROTEIN FATE_PROTEIN AND PEPTIDE SECRETION AND 
TRAFFICKING
0.071 0.020
PROTEIN FATE_PROTEIN MODIFICATION AND REPAIR_PROTEIN 
FOLDING AND STABILIZATION
0.132 0.000
PROTEIN SYNTHESIS_RIBOSOMAL PROTEINS: SYNTHESIS AND 
MODIFICATION_TRANSLATION FACTORS
0.001 0.005
PROTEIN SYNTHESIS_TRNA AND RRNA BASE MODIFICATION 0.241
TRANSCRIPTION 0.030
DNA METABOLISM 0.249
Downregulation corresponds to negative correlation and upregulation corresponds to positive correlation with the fosfomycin concentration. 
Numbers show false discovery rates (FDR). Only gene sets with FDR < 0.25 in at least one time point are shown; bold is used when FDR < 0.05.Petek et al. BMC Microbiology 2010, 10:159
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the first step of peptidoglycan biosynthesis (Figure 5).
This was observed at time point t40c4 only. The most
strongly induced of the mur  genes was that encoding
MurZ, a MurA homologue enzyme. Fosfomycin inhibits
both MurA and MurZ, which are essential to Gram posi-
tive bacteria [5]. Nevertheless, the murA gene (with two
probe sets on the chip: MurA, MurA_1; Figure 5) was not
found to be significantly differentially expressed. Interest-
ingly, some genes encoding enzymes acting in the final
phases of peptidoglycan synthesis - pbpA, bacA, and sgtB
- were more induced than the gene encoding the target
enzyme (Figure 5). This suggests that inhibition of MurA
and MurZ affects transcription of the whole metabolic
pathway. In contrast to Escherichia coli, peptidoglycan
biosynthetic genes in S. aureus are distributed evenly
throughout the chromosome and are regulated indepen-
dently. As shown by Sobral et al. [6], there is a striking
complexity of transcription level links that connect a
large number of diverse cellular functions to any particu-
lar step in cell wall synthesis.
Autolysin coding genes atl, lytH, SA0423, and SA2100
were downregulated at t40c4, whereas lytM was upregu-
lated by fosfomycin at that point (Figure 5) suggesting the
prevention of further degradation of peptidoglycan. As
well as in cell wall stress, gene atl has been found to be
downregulated in acid shock [7], SOS response and, cold
shock, but upregulated in stringent response [8].
A set of S. aureus genes responding to cell wall active
antibiotics, termed the "cell wall stress stimulon", were
first described by Utaida et al. [9]. They showed an
orchestrated response following treatment with antibiot-
ics acting at different stages of cell wall biosynthesis,
either intra- (D-cycloserine) or extra-cellularly (vanco-
mycin, oxacillin, bacitracin), at different exposure times
and concentrations. The qualitative comparison of differ-
ential expression of the cell wall stress stimulon genes in
our and previously described studies is presented in Table
2. Despite the different experimental conditions, the cell
wall stress stimulon genes react in a similar manner, inde-
pendently of the bacterial strain and incubation time.
Moreover, in our experiment, the transcriptional
response of these genes is seen to be time and concentra-
tion dependent (Table 2). Their expression is controlled
mainly by the vraSR two component system and it has
been shown that the VraSR regulon is induced specifi-
cally only by cell-wall-active antibiotics [10]. Fosfomycin
strongly induced the vraS (Table 2) and vraR (Additional
file 1) genes and many of the genes they regulate - not
only cell wall synthesis genes but also those for chaper-
ones, heat shock proteins and osmoprotectant transport-
ers. The rib  and  ure  operons, involved in cofactor
Figure 4 Verification of microarray results by qPCR. Differential expression of atl, murZ, oppB, ribB, and sgtB genes was measured after 40 min of 
treatment with 1 μg/ml (t40c1) and 4 μg/ml (t40c4) of fosfomycin. The histograms show log2 fold changes (log2FC). The filled bars show qPCR data 
and the patterned bars microarray data.Petek et al. BMC Microbiology 2010, 10:159
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biosynthesis and urea degradation and, which were
induced by some cell-wall-active antibiotics, were also
induced at the latest time point in our experiment.
A transcriptional response specific to MurA inhibition
We performed a meta-analysis to identify groups of genes
responding differently to fosfomycin and to other antibi-
otic treatments. For example, the transcriptional
response to ciprofloxacin [11], an inhibitor of bacterial
DNA gyrase, is clearly different from that of fosfomycin,
because the cell wall stress stimulon genes were not acti-
vated. Similarly, the transcriptional profile of the antisep-
tic compound triclosan, that targets fatty acid
biosynthesis [12], confirms the specificity of the cell wall
stress response. The effects of fosfomycin on S. aureus
metabolism, supported by our transcription data, are
schematized in Figure 6. The inhibition of MurA causes
accumulation of its substrate phosphoenolpyruvate (PEP)
which is known to act as a carbon starvation signal. PEP
accumulation was shown to be responsible for downregu-
lation of several central metabolism genes and nucleic
acid biosynthesis genes in different organisms including
bacteria [13]. A downregulation of pur and pyr operons
was observed at the latest time point. Downregulation of
both operons has also been reported in the SOS response
[8], acid-shock response [7], ciprofloxacin response [11]
and in the S. aureus MurF underexpression mutant [6].
In order to reach target enzymes MurA and MurZ, fos-
fomycin has to cross the cell membrane. Because of its
hydrophilic nature it uses the active transport systems
(ABC transport proteins), specifically the L-α-glycero-
phosphate and the glucose-6-phosphate uptake systems
[1]. The PEP phosphotransferase system (PTS) mediates
the uptake and phosphorylation of carbohydrates and
Figure 5 Visualization of S. aureus peptidoglycan metabolic pathway. Node colours correspond to fold changes of differentially expressed genes 
40 min after treatment with 4 μg/ml of fosfomycin (red - upregulated, green - downregulated, grey - genes not differentially expressed). Metabolites 
are represented by grey-shaded nodes without the plus sign on the connecting arcs.P
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Table 2: Expression of "cell wall stress stimulon" genes: comparison of current study with published results in the SAMMD.
N315 LOCUSa Gene 
Nameb
Expression fold changec Gene Product Descriptione TIGR 
Functional 
Group
t10c1 t20c1 t40c1 t10c4 t20c4 t40c4 Cell wall 
active 
antibioticsd
SA0909 fmt 2.65 1.83 3.23 + Fmt, autolysis and methicillin resistant-related 
protein
Cell envelope
SA1549 1.38 0.63 1.87 + hypothetical protein, similar to serine proteinase Protein fate
SA1659 prsA 1.57 0.94 1.89 + peptidyl-prolyl cis/trans isomerase homolog Protein fate
SA1691 sgtB 0.37 2.37 1.31 3.14 + hypothetical protein, similar to penicillin-binding 
protein 1A/1B
Cell envelope
SA1701 vraS 0.28 2.05 1.21 2.93 + two-component sensor histidine kinase Cellular 
processes
SA1702 2.25 1.29 3.34 + conserved hypothetical protein Unclassified
SA1703 2.63 1.47 3.54 + hypothetical protein Unclassified
SA1712 0.69 0.41 1.60 + conserved hypothetical protein Unclassified
SA1926 murZ 0.94 0.51 1.45 + UDP-N-acetylglucosamine 1-carboxylvinyl 
transferase 2
Cell envelope
SA2103 1.58 0.87 2.11 + hypothetical protein, similar to lyt divergon 
expression
Regulatory 
functions
SA2146 tcaA 0.27 2.07 1.27 2.69 + TcaA protein Energy 
metabolism
SA2220 0.95 0.47 1.48 + hypothetical protein Energy 
metabolism
SA2221 1.92 0.96 2.59 + hypothetical protein Unclassified
SA2297 0.37 + hypothetical protein, similar to GTP-
pyrophosphokinase
Unclassified
SA2343 -0.73 2.11 7.08 5.50 7.62 + hypothetical protein Unclassified
SA0423 -0.47 -1.34 - hypothetical protein, similar to autolysin 
(N-acetylmuramoyl-L-alanine amidase)
Unclassified
SA0905 atl -0.54 -1.24 - autolysin Cell envelope
-0.51 -1.19
a S. aureus N315 genome ORF locus.
b Previously described gene name.
c Gene expression log2 fold change of treated vs. non-treated bacteria. Abbreviations correspond to experimental design points.
d Previously reported expression increase (+) or decrease (-) of cell-wall-antibiotic treated vs. non-treated bacteria.
e Gene product functional annotation.Petek et al. BMC Microbiology 2010, 10:159
http://www.biomedcentral.com/1471-2180/10/159
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controls metabolism in response to carbohydrate avail-
ability, and can therefore affect the whole cell metabolic
rate [14]. GSEA shows that PTS was downregulated by
fosfomycin 20 and 40 minutes after treatment. This
downregulation could be a defense mechanism against
the influx of fosfomycin. It has been reported that PTS
mutant bacteria are highly resistant to fosfomycin [15]
and that some fosfomycin-resistant E. coli isolates have
altered  glpT  and/or  uhp  transport systems [16]. The
downregulation of PTS genes can also contribute to PEP
accumulation [13]. As shown in Figure 3 and Table 1,
transport processes in general were significantly down-
regulated. The majority of differentially expressed genes
in this group encode proteins that transport oligopep-
tides (opp genes), amino acids, sugars, polyamines (potA-
BCD) and cations into the cell. Genes encoding iron
transport and binding proteins, belonging to the Isd sys-
tem, were also downregulated similarly as in a MurF
underexpression mutant study [6]. However, a small pro-
portion of transport genes were upregulated, including
some amino acid and oligopeptide carrier genes and the
sodium/hydrogen exchanger genes mnhBCDEG.
The energy metabolism group, consisting of genes
involved in sugar metabolism, amino acid degradation
and TCA cycle, were generally downregulated (Figure 3),
consistent with a starvation response. The downregu-
lated amino acid metabolism genes include met and dap
operons; additionally, the aspartate family was shown to
be significantly downregulated by GSEA (Table 1).
Upregulated amino acid metabolism genes include genes
involved in cysteine biosynthesis and synthesis of cysta-
thionine. Various tRNA synthetases, probably connected
to amino acid biosynthesis, were also downregulated.
Strong downregulation of virulence genes by fosfomy-
cin was observed, especially 40 min after treatment.
These genes include hla, spa, aur, sspABC and 16 cap
genes (capA - capF) encoding capsular polysaccharide
synthesis enzymes. Capsular genes were also downregu-
lated in the SOS response [8], but upregulated by cyclos-
erine treatment [9], sigB mutant [17] and biofilm forming
S. aureus [18]. It has been shown that cap genes and vari-
ous virulence factors are regulated by Sae and Agr global
regulatory proteins. It was shown that Agr causes induc-
tion, and Sae repression, of cap genes [19,20], but in our
experiments none of these regulatory genes were differ-
entially expressed.
Conclusions
A pathway-based approach enabled us to determine that
the response of S. aureus to fosfomycin is not only time
but also concentration dependent, and that the major
transcriptional switch occurred after 20 to 40 min of
treatment. The fosfomycin response was similar to those
of other cell-wall-active antibiotics in the cell envelope
pathway and the cell wall stress stimulon genes. However,
in contrast to previously described cell-wall-active antibi-
otic treatments, we have identified several pathways and
genes downregulated by fosfomycin, such as transport,
nucleic acid biosynthesis, energy metabolism and viru-
lence genes. The downregulation of these pathways was
explained by a starvation response induced by PEP accu-
mulation. We have shown that transcriptomic profiling,
in combination with meta-analysis, is a valuable tool in
determining bacterial response to a specific antibiotic.
Methods
Bacterial growth conditions
Staphylococcus aureus, strain ATCC 29213 was cultured
in a small volume of cation-adjusted Mueller-Hinton
broth medium (Sigma-Aldrich) and grown in Erlenmeyer
flask on a gyratory shaker (200 rpm) at 37°C. The over-
night culture was diluted 100-fold in 300 ml of medium
and grown under the same conditions in 1-L Erlenmeyer
flasks until OD600 reached 0.3, which corresponded to the
early exponential stage of growth.
Antibiotic treatment
With the potential of testing new chemical entities in
mind, the experiment was designed to allow substances
slightly soluble in water to be tested. Fosfomycin (Sigma)
was diluted in DMSO (Sigma) to give final concentrations
of 5% DMSO with 1 (c1) and 4 (c4) μg/ml of fosfomycin.
DMSO alone was added to the control cultures (c0), to
normalize the effects of DMSO treatment.
Appropriate fosfomycin concentrations were deter-
mined in a preliminary growth study (data not shown).
Growth rate (measured as OD) and proportion of live
cells determined with the LIVE/DEAD BacLight™ Bacte-
rial Viability Kit (Invitrogen) were monitored for a range
Figure 6 Fosfomycin effects on S. aureus metabolism supported 
by transcriptional data in this study. Processes in red ovals were in-
duced and those in green ovals were repressed by fosfomycin treat-
ment.Petek et al. BMC Microbiology 2010, 10:159
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of concentrations from 1 to 1024 μg/ml. For the microar-
ray experiments concentrations were selected that did
not affect bacterial growth in the first few hours after
treatment. The experiment was repeated four times, from
four independently grown bacterial inoculates, thus
yielding 40 samples.
Sampling and RNA preparation
The bacterial culture (prepared as described above) was
divided into 10 flasks (19 ml per flask) containing previ-
ously prepared fosfomycin solutions. Cultures were
grown as described above and sampled (7 ml per flask) at
the time of treatment (t0) and 10 (t10), 20 (t20) and 40
minutes (t40) after treatment. The OD of each culture
was measured immediately before sampling (data not
shown) and the cultures were stabilized using RNApro-
tect Bacteria Reagent (Qiagen), following the manufac-
turers protocol. The bacterial pellets were stored at -
80°C.
RNA was isolated from bacterial pellets by enzymatic
cell wall lysis [21] followed by RNeasy Mini Kit (Qiagen)
purification. Two hundred μl of lysis buffer (20 mM TRIS
HCl, 50 mM EDTA, 200 g/l sucrose, pH 7.0), containing
lysostaphin (Sigma; 15 μg/μL) was added to the cell pellet
and incubated on ice for 20 minutes. The lysate was
transferred to a water bath at 37°C for 3 minutes. After
incubation, 200 μl of 2% SDS and 7 μl of proteinase K
were added and the lysate incubated at room temperature
for 15 minutes. 800 μl of the RLT buffer (from RNeasy
Kit) was added to the lysate, vortexed vigorously and son-
icated for 5 minutes at 56°C. After the addition of 600 μl
of absolute ethanol, the lysate was transferred to the
RNeasy Mini columns and centrifuged until all the lysate
was used. The remaining steps were as described in
RNeasy Mini Kit manufacturer's protocol. The elution
was performed twice with pre-heated (60°C) water and 5
minutes incubation time. To remove remaining genomic
DNA, total RNA samples were treated with DNase I
(Deoxyribonuclease I, amplification grade, Invitrogen), as
recommended by manufacturer, only with lower opti-
mized DNase concentration of 0.25 U per μg of total
RNA. The RNA was purified and concentrated using
RNeasy Min Elute Kit (Qiagen). Finally the RNA was
checked for quality and quantity using absorbance mea-
surements (Nanodrop) and agarose gel electrophoresis
(data not shown). Two samples did not meet the quality
demands and were not used for microarray hybridization.
Microarray hybridization
RNA was labelled and hybridized to GeneChip® S. aureus
Genome Arrays (Affymetrix) according to the GeneChip®
Expression Analysis Technical Manual, the section for
prokaryotic antisense arrays. Targets were prepared by
cDNA synthesis with random primers, RNA degradation,
cDNA purification and fragmentation, followed by termi-
nal labelling with biotin. Labelled cDNA was hybridized
on the microarrays, which were subsequently washed,
stained and scanned.
Quality control and statistical data analysis
Data was analysed with bioconductor (R version 2.10.0;
http://www.bioconductor.org) packages affy [22], gcrma
[23] and limma [24]. Quality control of the microarray
consisted of visual inspection of various diagnostic plots,
namely boxplots of transcript intensities, image plots of
arrays and MA plots of raw data. Additionally, parame-
ters from the Affymetrix software were evaluated. More-
over, RLE (Relative Log Expression) and NUSE
(Normalized Unscaled Standard Error) plots were con-
structed [25]. Of 38 analyzed arrays, one did not meet the
quality requirements and was therefore excluded from
further analysis.
Data pre-processing and expression value calculation
were carried out using two procedures, yielding 2 sepa-
rate datasets. In the first, a combination of rma convolu-
tion method for background adjustment [26],
invariantset for normalization [27], pm correction as
from the mas manual, and liwong method summarization
[27,28] were applied. In the second procedure, all the pre-
processing steps were performed simultaneously using
gcrma [23].
In order to find differentially expressed genes a statisti-
cal model was formulated (p < 0.05) to compare gene
expression in bacteria exposed to fosfomycin concentra-
tions c1 and c4 with that of the control (c0) at a given
time point. To decrease false discovery rate, the results
coming from different pre-processing procedures were
combined and only the intersection of genes, differen-
tially expressed following both procedures were taken
into account for the biological interpretation of the
results [29].
Pathway analysis
Biochemical reactions from S. aureus metabolic network
reconstruction  iSB619 [4] were obtained from BIGG
database http://bigg.ucsd.edu/ and coupled with TIGR S.
aureus  a n n o t a t i o n  [ 3 0 ]  d o w n l o a d e d  f r o m  T I G R  C M R
database http://cmr.tigr.org/tigr-scripts/CMR/
CmrHomePage.cgi. Pathway database and expression
profiles for all experimental time points were imported to
Pathway Studio software (version 4.0; Ariadne Genomics
Inc). Differentially expressed genes were queried for pres-
ence in metabolic network. Pathways constructed in
Pathway Studio were examined and interpreted manually.
Pathway Studio .gpc file is available as Additional file 2.
Gene set enrichment analysis (GSEA) [31] was applied
to search for groups of genes involved in the same pro-
cesses (gene sets) that were altered significantly by fosfo-Petek et al. BMC Microbiology 2010, 10:159
http://www.biomedcentral.com/1471-2180/10/159
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mycin treatment. Individual GSEA was performed for a
data set including control and both fosfomycin treatment
concentrations (1 and 4 μg/ml) for the selected time
point. Gcrma-normalized data was filtered for signal
intensity greater than 10. The signal intensities from the
same time point were overlapped on 40 gene sets (see
Additional file 3) based on TIGR S. aureus annotation
[30] and measured for the enrichment of genes at the top
or bottom of the gene list to determine their correlation
with the logarithm of fosfomycin concentration (gene
set's phenotype). The GSEA parameters used included:
Pearson metric and gene set size restrictions, 10 mini-
mum, 500 maximum. Gene sets significantly modified by
fosfomycin treatment were identified using a multiple
hypothesis testing FDR < 0.25. GSEA was performed for
each time point (10, 20 and 40 min) at which gene expres-
sion was correlated with fosfomycin concentration. Posi-
tive correlation was interpreted as up-regulation of a gene
set resulting from drug treatment; a negative correlation
was interpreted as down-regulation.
Meta-analysis: integration of gene expression data from 
other sources
Our experimental data was compared to other publicly
available S. aureus transcriptomic data. To ease the com-
parison, the recently published "Staphylococcus aureus
microarray meta-database" (SAMMD) was used [3]. The
qualitative transcriptional profiles (up or downregula-
tion) were coupled with the quantitative transcriptional
profile of fosfomycin to a single spreadsheet (Additional
file 1) in order to analyze the similarities and differences
between different responses.
Quantitative real-time PCR (qPCR)
The purified RNA samples from experimental points
t40c0, t40c1 and t40c4 were reverse transcribed using
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems). The acquired cDNA was used to validate the
microarray differential expression for genes listed in
Table 3. All qPCR reactions were performed on a Light-
Cycler LC480 Detection System (Roche) in 384-well plate
format using universal cycling conditions (2 min at 50°C,
10 min at 95°C, followed by 50 cycles of 15 s at 95°C and 1
min at 60°C). Real-time PCR was performed in a final
reaction volume of 5 μL containing 2 μL of diluted cDNA
sample, 1× primer-probe mix (TaqMan® Gene Expression
Assay, Applied Biosystems) and 1× TaqMan® Universal
PCR Master Mix (Applied Biosystems). Each sample
cDNA was tested for five target genes: atl, murZ, oppB,
ribB, sgtB and the endogenous control 16S rRNA [32].
The TaqMan® chemistry based primers and probes were
designed and synthesized by Applied Biosystems (Table
3). Each reaction was performed in two replicate wells in
two dilutions on the same 384-well plate. An automated
liquid handling system (Multiprobe® II plus ex, PerkinEl-
m e r )  w a s  u s e d  t o  p r e p a r e  c D N A  d i l u t i o n s ,  t o  p i p e t t e
cDNA samples and master mixes onto the 384-well
plates.
Data were analyzed using the LightCycler® 480 1.5.0.39
Software. The 2nd derivate method was used for all ampl-
icons to determine Cp values. The standard curve
method was used for relative gene expression quantifica-
tion, and the transcript accumulation of each gene was
normalized to 16S rRNA. The amplification efficiency
and linear range of amplification were followed for each
amplicon on each plate by analyzing a reference sample
pool in four dilution steps of cDNA with two replicate
wells per dilution step. Each sample was analyzed in two
dilutions and two replicates per dilution step. Only sam-
ples where the ΔCp between two dilutions of target gene
did not deviate by more than 0.5 from ΔCp of the refer-
ence gene were used for relative quantification. The fold
changes for each experimental point were calculated as a
quotient of average transcript abundances between
treated and control samples from three independent bio-
logical replicates in each time point.
Microarray dataset accession number
Microarray data analyzed in this study have been depos-
ited in the Gene Expression Omnibus database with
accession number GSE15394.
Table 3: Primer and probe sequences used for qPCR analysis.
Gene 
Name
Forward Primer Reverse Primer Probe
murZ TGGTCCTTCATTTGTAACTGATACGATTT CCCATGCGCTTTAATTCTTCAACAT CCGGAGCGTTTTAAAC
atl CCCTACTACACCATCAAAACCAACA TGTGCGACACCATTGTTTGC ACACCGTCGAAACCAT
ribB CGTGCCATGAGTGGTAACG GTTCATCTACATGACCGAGGACAAA ATGTCCACCAAACCTAC
sgtB GAGCTTTATTTTCAACGATTAGCGACA AATTTTTGACAACTTGTTGTGTAATGGTACTAC CACCTTGCACATCTC
oppB TTTAGGTGTTGCAGCAGCTACT GTACAGCAAGTACAAAAGATGGTACAGA CAACCCAAGAATTTTGPetek et al. BMC Microbiology 2010, 10:159
http://www.biomedcentral.com/1471-2180/10/159
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